Skip to main content

Table 1 Baseline Characteristics

From: Benefits of successful percutaneous coronary intervention in chronic total occlusion patients with diabetes

 

No Diabetes

Diabetes

p Value

(n = 702)

(n = 374)

Age, yrs

60.23 ± 10.78

61.35 ± 10.55

0.101

Males, n%

609(86.75)

333(89.04)

0.280

BMI, kg/m2

25.25 ± 3.25

25.11 ± 3.03

0.474

SBP, mmHg

127.70 ± 20.23

126.96 ± 19.25

0.560

DBP, mmHg

72.87 ± 12.19

71.19 ± 11.99

0.031

Smoking, n%

275(39.17)

125(33.42)

0.063

Hypertension, n%

413(58.83)

251(67.11)

0.008

Previous MI, n%

298(42.45)

145(38.77)

0.243

Previous PCI, %

338(48.15)

208(55.61)

0.020

Previous CABG, %

20(2.85)

15(4.01)

0.306

Previous stroke, n%

73(10.40)

57(15.24)

0.020

Chronic pulmonary disease, n%

13(1.85)

9(2.41)

0.540

Peripheral artery disease, n%

14(1.99)

13(3.48)

0.139

Family history of CHD, n%

23(3.28)

21(5.61)

0.065

WBC, *109/L

6.98 ± 2.09

6.94 ± 1.97

0.783

Platelet, *109/L

208.63 ± 64.78

206.42 ± 65.43

0.596

Hemoglobin, g/L

141.24 ± 19.35

136.64 ± 18.96

 < 0.001

FPG, mmol/ L

5.55 ± 1.82

8.09 ± 3.53

 < 0.001

TC, mmol/ L

3.44 ± 1.06

3.28 ± 0.91

0.008

TG, mmol/ L

1.67 ± 1.02

1.66 ± 1.23

0.917

LDL-C, mmol/ L

1.96 ± 0.93

1.78 ± 0.77

0.001

HDL-C, mmol/ L

1.03 ± 0.42

0.98 ± 0.34

0.087

ALT, U/L

33.56 ± 47.35

28.73 ± 25.79

0.068

AST, U/L

29.35 ± 43.62

23.80 ± 19.81

0.004

Scr, μmol/ L

89.24 ± 64.23

94.90 ± 55.80

0.151

eGFR, mL/min per 1.73 m2

83.34 ± 23.22

80.40 ± 27.85

0.081

CrCL, ml/min

88.17 ± 30.37

84.03 ± 32.68

0.040

Uric acid, μmol/ L

355.90 ± 95.27

337.98 ± 105.21

0.005

Hyperuricemia, n%

145(20.66)

63(16.84)

0.132

cTnI, ng/mL

1.01 ± 9.32

0.62 ± 3.93

0.433

NT-proBNP, pg/ml

294.80(115.00,956.93)

368.60(127.90,1264.00)

0.040

CK, IU/L

146.16 ± 343.72

106.19 ± 123.31

0.010

CK-MB, IU/L

18.58 ± 34.10

14.76 ± 14.60

0.019

LVEF, %

50.53 ± 9.47

49.46 ± 10.25

0.096

Dyspnea(NYHA functional class), n%

  

0.273

I

194(27.64)

96(25.67)

 

II

340(45.58)

180(48.13)

 

III

145(20.66)

75(20.05)

 

IV

23(3.28)

23(6.15)

 

NYHA functional class III/ IV

168(23.93)

98(26.20)

0.411

  1. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, CHD coronary atherosclerotic heart disease, WBC white blood cell, FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol, ALT alanine aminotransaminase, AST aspartate aminotransferase, Scr serum creatinine, eGFR estimated glomerular filtration rate, CrCL creatinine clearance, cTnI cardiac troponin I, NT-proBNP N-terminal pro-B type natriuretic peptide, CK creatine kinase, CK-MB creatine kinase MB, LVEF left ventricular ejection fraction, NYHA New York Heart Association
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840